Drug recall · September 30, 2015
BLEPHAMIDE recall
Why: Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
BLEPHAMIDE (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10 %/0.2 %, 3.5 g tube, Rx only, ALLERGAN, Irvine, California 92612, NDC 0023-0313-04, UPC 3 00230 31304 9.
- Lots / codes
Lot #: 86430, Exp 09/17; 87806, Exp 02/18; 88147, Exp 03/18
- Quantity
- 337 tubes
- Company
- Allergan Sales, LLC, Waco, TX
- Distribution
- Nationwide, Puerto Rico, and Barbados
- Initiated
- August 24, 2015 · Voluntary: Firm initiated
- Classified
- September 22, 2015
- Reported
- September 30, 2015
- Ended
- April 19, 2017
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Prednisolone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.